DOI QR코드

DOI QR Code

A spindle cell squamous cell carcinoma on the cheek presenting with in-transit metastases and a satellite lesion

  • Lee, Eui-Tae (Department of Plastic and Reconstructive Surgery, Chungbuk National University College of Medicine)
  • Received : 2019.11.04
  • Accepted : 2019.12.10
  • Published : 2020.02.20

Abstract

Spindle cell squamous cell carcinoma (SpSCC) is a biphasic tumor composed of squamous cell epithelial and spindle cell mesenchymal components, both of which are malignant. Cutaneous SpSCC can cause diagnostic and therapeutic difficulties because of its rarity, heterogeneity, morphological similarity to other cutaneous spindle cell neoplasms, and uncertain pathogenesis and prognosis, particularly when the squamous cell carcinoma component is minimal or missing. Intransit metastasis and satellite lesion (satellitosis) constitute a spectrum of non-nodal regional metastases. Here the author reports the first known case of cutaneous SpSCC presenting with intransit metastases and a satellite lesion, which were exceptionally aggressive. A 77-year-old female patient presented with a 3×3×0.5 cm mass on her right cheek. Despite wide excision and postoperative radiation, the patient resulted in local recurrence and multiple distant metastases within 3 months. If many high-risk factors-particularly satellitosis and in-transit metastases are observed in a tumor with epithelial to mesenchymal transition, then further wide excision and adjuvant chemoradiation should be considered early in the treatment process. A multidisciplinary approach could be the key to cure the most aggressive malignancies of the skin, as in other organs.

Keywords

References

  1. Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012.
  2. Lee JH, Lee YB, Kim JW, Yu DS. Cutaneous spindle cell squamous cell carcinoma. Ann Dermatol 2015;27:113-5. https://doi.org/10.5021/ad.2015.27.1.113
  3. Kim YD, Suhr KB, Lee JH, Park JK. A clinical and histopathological study of cutaneous squamous cell carcinoma. Korean J Dermatol 2002;40:25-30.
  4. Chi DH, Sung KJ, Koh JK. A clinical observation of primary epithelial skin cancers. Korean J Dermatol 1995;33:1085-90.
  5. Hayes AJ, Clark MA, Harries M, Thomas JM. Management of in-transit metastases from cutaneous malignant melanoma. Br J Surg 2004;91:673-82. https://doi.org/10.1002/bjs.4610
  6. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199-206. https://doi.org/10.1200/JCO.2009.23.4799
  7. Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:472-92. https://doi.org/10.3322/caac.21409
  8. Ma JH, Wu A, Veness M, Estall V, Hong A, Borg M, et al. Intransit metastasis from squamous cell carcinoma. Dermatol Surg 2016;42:1285-92. https://doi.org/10.1097/DSS.0000000000000864
  9. Altunay I, Cerman AA, Sakiz D, Ates B. Marjolin's ulcer presenting with in-transit metastases: a case report and literature review. Ann Dermatol 2015;27:442-5. https://doi.org/10.5021/ad.2015.27.4.442
  10. Carucci JA, Martinez JC, Zeitouni NC, Christenson L, Coldiron B, Zweibel S, et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004;30:651-5. https://doi.org/10.1097/00042728-200404020-00013
  11. Copcu E, Dikicioglu E, Sivrioglu N, Meteoglu I. Subcutaneous nodules on the face: acantholytic in-transit cutaneous metastasis. Dermatol Surg 2004;30:1415-9. https://doi.org/10.1111/j.1524-4725.2004.30438.x
  12. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992;26:976-90. https://doi.org/10.1016/0190-9622(92)70144-5
  13. Lewis JE, Olsen KD, Sebo TJ. Spindle cell carcinoma of the larynx: review of 26 cases including DNA content and immunohistochemistry. Hum Pathol 1997;28:664-73. https://doi.org/10.1016/S0046-8177(97)90175-1
  14. Burston J, Clay RD. The problems of histological diagnosis in baso-squamous cell carcinoma of the skin. J Clin Pathol 1959;12:73-9. https://doi.org/10.1136/jcp.12.1.73
  15. Bigby SM, Charlton A, Miller MV, Zwi LJ, Oliver GF. Biphasic sarcomatoid basal cell carcinoma (carcinosarcoma): four cases with immunohistochemistry and review of the literature. J Cutan Pathol 2005;32:141-7. https://doi.org/10.1111/j.0303-6987.2005.00276.x
  16. Ribatti D. Epithelial-mesenchymal transition in morphogenesis, cancer progression and angiogenesis. Exp Cell Res 2017;353:1-5. https://doi.org/10.1016/j.yexcr.2017.02.041
  17. Compton LA, Murphy GF, Lian CG. Diagnostic immunohistochemistry in cutaneous neoplasia: an update. Dermatopathology (Basel) 2015;2:15-42. https://doi.org/10.1159/000377698
  18. Folpe AL, Cooper K. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors. Arch Pathol Lab Med 2007;131:1517-24. https://doi.org/10.5858/2007-131-1517-BPIDIP
  19. Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:122-37. https://doi.org/10.3322/caac.21389
  20. Work Group; Invited Reviewers, Kim JYS, Kozlow JH, Mittal B, Moyer J, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol 2018;78:560-78. https://doi.org/10.1016/j.jaad.2017.10.007